Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released Aug 9, 2012, during market hours
10-Q filed Aug 9, 2012, 40 days after period end · 0001193125-12-346339
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2012 | Q2 2011 |
|---|---|---|
| Revenue | $28.50M | $27.14M |
| Net Income | $774.00K | $1.37M |
| EPS Diluted | $0.02 | $0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 9, 2012 · 40 d after period end
